Kim Peters
Adult Health · Mountain Home, ARNPI 1063786424
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,075 and has fallen 95.7% since, to $47 in 2025.
Across 130 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$522
- Novo Nordisk$225
- GSK$210
- Amgen$209
- Lilly USA, LLC$156
- Boehringer Ingelheim$137
- plus $892 from 17 others
What the payments were for
- Food & beverage$2,351100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $522 |
| Novo Nordisk | 8 | $225 |
| GSK | 13 | $210 |
| Amgen | 12 | $209 |
| Lilly USA, LLC | 9 | $156 |
| Boehringer Ingelheim | 8 | $137 |
| Pharmacosmos Therapeutics Inc. | 1 | $136 |
| Astellas Pharma US Inc | 7 | $129 |
| Otsuka America Pharmaceutical, Inc. | 6 | $109 |
| AstraZeneca | 7 | $104 |
| Bayer | 3 | $87 |
| Mylan Specialty L.p. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Boston Scientific | 1 | $39 |
| Lundbeck LLC | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Philips North America LLC | 1 | $19 |
| Pfizer | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Eisai Inc. | 1 | $15 |
| Exeltis, USA Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Monoferric$136
- Ozempic$125
How this compares
$2,351 in reported general payments places this provider in the 75th percentile of 154 adult health providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 56 | $62,342 |
| JardianceEmpagliflozin | 53 | $43,282 |
| EliquisApixaban | 30 | $23,912 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $13,788 |
| Repatha SureclickEvolocumab | 15 | $9,360 |
| JanuviaSitagliptin Phosphate | 11 | $9,082 |
| Spiriva RespimatTiotropium Bromide | 12 | $6,060 |
| Duloxetine Hcl | 94 | $2,326 |
| Pregabalin | 13 | $1,951 |
| Fluticasone Propionate | 29 | $1,878 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $1,785 |
| Atorvastatin Calcium | 211 | $1,677 |
| Gabapentin | 74 | $1,665 |
| Carbamazepine ErCarbamazepine | 16 | $1,497 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 65 | $1,148 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $225 | $62,34256 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $137 | $49,34265 claims |
| PfizerEliquis | $18 | $23,91230 claims |
| GSKTrelegy Ellipta | $210 | $13,78819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 154 adult health providers in Arkansas.
Other adult health in Mountain Home
- Holly MooreLittle Rock$59K
- Deborah ShipmanJonesboro$41K
- Lisa HurdJonesboro$12K
- Kari SchrankFayetteville$9K
- Amanda McClureFayetteville$9K
- Gina NullFort Smith$8K
- Darren CompasBentonville$8K
- Lisa HarveyHot Springs$8K
- Abby MartensSpringdale$7K
- Marie JonesFayetteville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.